Silverfin false false 31/12/2025 31/12/2025 01/10/2024 no description of principal activity Hyunwoo Shin 01/10/2024 15989482 2025-12-31 15989482 bus:Director1 2025-12-31 15989482 core:CurrentFinancialInstruments 2025-12-31 15989482 2024-10-01 2025-12-31 15989482 bus:Micro-entities 2024-10-01 2025-12-31 15989482 bus:FilletedAccounts 2024-10-01 2025-12-31 15989482 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-12-31 15989482 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-12-31 15989482 bus:Director1 2024-10-01 2025-12-31 iso4217:GBP xbrli:pure

Company No: 15989482 (England and Wales)

PNAS THERAPEUTICS LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 DECEMBER 2025
PAGES FOR FILING WITH THE REGISTRAR

PNAS THERAPEUTICS LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 DECEMBER 2025

Contents

PNAS THERAPEUTICS LTD

BALANCE SHEET

AS AT 31 DECEMBER 2025
PNAS THERAPEUTICS LTD

BALANCE SHEET (continued)

FOR THE FINANCIAL PERIOD FROM 01 OCTOBER 2024 TO 31 DECEMBER 2025
31.12.2025
£
Current assets 37,808
Prepayments and accrued income 511
Creditors: amounts falling due within one year ( 24,825)
Net current assets 13,494
Total assets less current liabilities 13,494
Accruals and deferred income ( 22,379)
Net liabilities ( 8,885)
Capital and reserves ( 8,885)

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 15989482). The address of its registered office is 125 Wood Street, London, EC2V 7AW, United Kingdom.

2. Employees

Period from
01.10.2024 to
31.12.2025
Number
Monthly average number of persons employed by the Company during the financial period, including the director 1

For the financial period ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of PNAS Therapeutics Ltd (registered number: 15989482) were approved and authorised for issue by the director on 28 April 2026 and were signed on its behalf by:

Hyunwoo Shin
Director